Dongwha Pharm & Pfizer Pharmaceuticals Korea extend sales & distribution agreement of CNS products

Published: 2018-04-16 17:07:11

Updated: 2018-04-16 17:07:11

Dongwha Pharm(CEO/President Kwang-Ryul Yoo) announced it has extended a sales and distribution agreement of Pfizer Pharmaceuticals Korea’s major CNS(central nervous system) products at Pfizer Tower on the 10^th of April.

Dongwha Pharm and Pfizer Pharmaceuticals Korea made a partnership in 2015, and have sold and distributed 3 CNS products, such as Zoloft, a SSRI(Selective Serotonin Reuptake Inh...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.